Live from the NIH registry
Studies recruiting near Bonita Springs right now
Top 25 of 298 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (18.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Fort Myers, Florida (18.7 mi)
· Sponsor: AstraZeneca
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Group of Florida - Fort Myers Retina Center — Fort Myers, Florida (18.7 mi)
· Sponsor: Boehringer Ingelheim
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy
N/A
Interventional 105 participants sought
NCH Heart Institute — Naples, Florida (14.8 mi)
· Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Endocardial Mapping With the CoreMap EP Mapping System
Persistent Atrial Fibrillation
N/A
Interventional 245 participants sought
NCH Downtown Baker Hospital — Naples, Florida (14.8 mi)
· Sponsor: CoreMap Inc.
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care - Fort Myers South — Fort Myers, Florida (18.7 mi)
· Sponsor: R1 Therapeutics
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Florida Cancer Specialists - SOUTH - SCRI - PPDS — Fort Myers, Florida (18.7 mi)
· Sponsor: Hoffmann-La Roche
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Fort Myers, Florida (18.7 mi)
· Sponsor: AstraZeneca
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Advanced Research for Health Improvement, LLC — Naples, Florida (14.8 mi)
· Sponsor: Boehringer Ingelheim
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Southwest Florida Proton Center — Fort Myers, Florida (18.7 mi)
· Sponsor: Proton Collaborative Group
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists South / Sarah Cannon Research Institute — Bonita Springs, Florida (1.2 mi)
· Sponsor: American Society of Clinical Oncology
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Royal Palm Clinical Research — Fort Myers, Florida (18.7 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
NCH Pulmonary Critical Care — Naples, Florida (14.8 mi)
· Sponsor: Synairgen Research Ltd.
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
Aqualane Clinical Research — Naples, Florida (14.8 mi)
· Sponsor: Syndeio Biosciences, Inc
LMN-201 for Prevention of C. Difficile Infection Recurrence
Clostridioides Difficile Infection
Phase 2, Phase 3
Interventional 375 participants sought
GI PROS Research — Naples, Florida (14.8 mi)
· Sponsor: Lumen Bioscience, Inc.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Florida Cancer Specialists - South ( Site 7001) — Fort Myers, Florida (18.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Phase 2
Interventional 435 participants sought
Research Site — Naples, Florida (14.8 mi)
· Sponsor: AstraZeneca
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Florida Cancer Specialists — Bonita Springs, Florida (1.2 mi)
· Sponsor: Pfizer
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Southwest General Healthcare Center — Fort Myers, Florida (18.7 mi)
· Sponsor: Housey Healthcare ULC
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
GenesisCare USA - FGO — Fort Myers, Florida (18.7 mi)
· Sponsor: NRG Oncology
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (18.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (18.7 mi)
· Sponsor: Merus B.V.
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
Retina Consultants of Southwest Florida - Naples — Naples, Florida (14.8 mi)
· Sponsor: Amgen
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Florida Cancer Specialists - South ( Site 7002) — Fort Myers, Florida (18.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
Advance Retina Institute — Bonita Springs, Florida (1.2 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.